Viewing StudyNCT05862272



Ignite Creation Date: 2024-05-06 @ 7:01 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05862272
Status: RECRUITING
Last Update Posted: 2024-03-15
First Post: 2023-05-08

Brief Title: A Phase 3B Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Women with Uterine Fibroids or Endometriosis
Sponsor: Sumitomo Pharma Switzerland GmbH
Organization: Sumitomo Pharma Switzerland GmbH

Conditions & Keywords Data

Conditions:
Name
Endometriosis
Uterine Fibroids
Keywords:
Name View
Norethindrone acetate View
Uterine Leiomyomas View
Fibroids View
Endometriosis View
Bone Mineral Density View
Relugolix View
Estradiol View